Quantcast

Latest Macular degeneration Stories

2015-04-15 08:32:04

New CEO to Lead Market Expansion of Novel Treatment for Advanced Macular Degeneration SARATOGA, Calif., April 15, 2015 /PRNewswire/ -- VisionCare Ophthalmic Technologies ("VisionCare"),

2015-04-06 08:26:10

LONDON, April 6, 2015 /PRNewswire/ -- Report DetailsAnalysis of revenues and R&D prospects for those eye drugs - you explore potentialsWhat's the future for treating disorders

2015-03-30 08:32:19

Efficacy and Safety of Long-term, Continuous Anti-VEGF will be Assessed in Phase 2 Study CUMBERLAND, R.I., March 30, 2015 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc.

2015-03-26 23:12:56

Market Publishers Ltd informs that new reports by GlobalData have been recently uploaded to its catalogue. London, UK (PRWEB) March 25, 2015 Market Publishers

2015-03-26 12:28:26

LONDON, March 26, 2015 /PRNewswire/ -- Report Details Analysis of revenues and R&D prospects for those eye drugs - you explore potentials What's the future

2015-03-25 12:30:39

Diabetic retinopathy in patients with DME is the fourth approved indication for EYLEA in the U.S. TARRYTOWN, N.Y., March 25, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.

2015-03-19 23:01:04

Having good vision does not mean your eyes are healthy.

2015-03-19 12:28:49

DALLAS, March 19, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Lucentis (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023" market research

2015-03-18 12:28:16

Biotech Veteran Will Lead Clinical Development Efforts of Encapsulated Cell Therapy in Ophthalmology CUMBERLAND, R.I., March 18, 2015 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc.


Word of the Day
gubbings
  • The parings of haberdine; also, any kind of fragments.
The word 'gubbings' is a variant of the word 'gobbon', meaning 'a portion, gobbet.'